Pediatric Patients With Solid or Hematological Tumor Disease: Vancomycin Population Pharmacokinetics and Dosage Optimization. - Aix-Marseille Université Accéder directement au contenu
Article Dans Une Revue Therapeutic Drug Monitoring Année : 2016

Pediatric Patients With Solid or Hematological Tumor Disease: Vancomycin Population Pharmacokinetics and Dosage Optimization.

Résumé

In pediatric cancer patients, determination of optimal vancomycin dosage is essential because of high risk of inadequate concentrations and bacterial resistance. The aim of this study was to determine vancomycin pharmacokinetic parameters in this population and propose dosage optimization to achieve optimal concentration.
Fichier non déposé

Dates et versions

hal-01776345 , version 1 (24-04-2018)

Identifiants

Citer

Romain Guilhaumou, Amelie Marsot, Julien Dupouey, Claire Galambrun, Audrey Boulamery, et al.. Pediatric Patients With Solid or Hematological Tumor Disease: Vancomycin Population Pharmacokinetics and Dosage Optimization.. Therapeutic Drug Monitoring, 2016, 38 (5), pp.559 - 566. ⟨10.1097/FTD.0000000000000318⟩. ⟨hal-01776345⟩
67 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More